COMMUNIQUÉS West-GlobeNewswire

Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference

02/05/2018 - 14:00

DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. Michelle [...]

Selecta Biosciences Announces Date of First Quarter 2018 Financial Results Conference Call

02/05/2018 - 14:00

WATERTOWN, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer

02/05/2018 - 14:00

WALTHAM, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced the appointment of J. Alan Butcher as executive vice president and chief business officer effective immediately [...]

Jounce Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018

02/05/2018 - 14:00

CAMBRIDGE, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Cellectar Receives Rare Pediatric Disease Designation for CLR 131 to Treat Neuroblastoma

02/05/2018 - 14:00

MADISON, Wis., May 02, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]

Profound Medical to Release First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow

02/05/2018 - 14:00

TORONTO, May 02, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to offer a therapeutic platform that provides the precision of real-time MR [...]

Immunomedics to Report Third Quarter Fiscal 2018 Results and Host Conference Call and Webcast on May 9, 2018

02/05/2018 - 14:00

MORRIS PLAINS, N.J., May 02, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that it will host a conference call on Wednesday, May 9, 2018 at 5:00 p.m. [...]

Cellaria Forms Collaborative Partnership with SBH Sciences

02/05/2018 - 14:00

Combines SBH’s assay services with Cellaria’s patient-specific cell models and cell culture media products Cambridge, Mass. and Natick, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Cellaria, LLC , a scientific innovator that [...]

Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S.

02/05/2018 - 14:00

MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Reality television personality Cameran Eubanks and Dermira, Inc. (NASDAQ: DERM ) announced today that they are collaborating on a new educational campaign aimed at [...]

aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting

02/05/2018 - 14:00

– Identification of T Cell Immunomodulatory Domain in Resokine – SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of [...]

Atlantic Healthcare completes patient enrollment to its Phase 3 study of alicaforsen to treat IBD Pouchitis

02/05/2018 - 14:00

Study completion and top-line data expected in Q1 2019 CAMBRIDGE, U.K., May 02, 2018 (GLOBE NEWSWIRE) -- Atlantic Healthcare plc (Atlantic Healthcare), an emerging trans-Atlantic pharmaceutical company with a core focus [...]

Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10

02/05/2018 - 13:57

BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), today announced that management will host a conference call and webcast slide presentation on Thursday, May 10, at 4:30 p.m. ET to [...]

Insmed Reports First Quarter 2018 Financial Results and Provides Business Update

02/05/2018 - 13:30

Submitted NDA to FDA for Amikacin Liposome Inhalation Suspension (ALIS) in NTM lung disease caused by MAC; anticipates priority review Actively preparing for potential product launch of ALIS in 4Q 2018 BRIDGEWATER, N.J [...]

Neos Therapeutics to Host First Quarter 2018 Financial Results Conference Call on May 9, 2018

02/05/2018 - 13:30

DALLAS and FORT WORTH, Texas, May 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) [...]

Marinus Pharmaceuticals Provides Business Update and First Quarter 2018 Financial Results

02/05/2018 - 13:30

RADNOR, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS ) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy [...]

Otonomy to Report First Quarter 2018 Financial Results and Provide Corporate Update

02/05/2018 - 13:30

Webcast and Conference Call to be Held at 4:30 p.m. EDT on May 9, 2018 SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative [...]

Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies

02/05/2018 - 13:30

– Newly issued patent expands protection for tipifarnib in U.S., provides exclusivity in certain CXCL12-expressing cancers to 2037 – – Second U.S. patent for tipifarnib reinforces potential for broader strategy to [...]

Avadel Pharmaceuticals Reports First Quarter 2018 Results

02/05/2018 - 13:30

NOCTIVA™ launch underway across the U.S. FT 218 granted Orphan Drug Designation Generated revenue of $33.3 million DUBLIN, Ireland, May 02, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL ) today [...]

PCI Biotech: Invitation to first quarter 2018 presentation

02/05/2018 - 13:24

Oslo,Norway, 2 May 2018 - PCI Biotech invites to a presentation of the company's first quarter 2018 report on Tuesday 8 May 2018 at Oslo Cancer Cluster Innovation Park. Time: Tuesday May 8, 08:30am - 09:30am CEST (local [...]